Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | 153.51B | 156.88B | 189.54B | 179.59B |
| Cost of revenue | 155.63B | 136.36B | 151.40B | 144.33B |
| Research and development | 11.15B | 5.78B | 5.62B | 5.20B |
| Selling, general and administrative | 8.97B | 9.30B | 9.54B | 8.98B |
| Operating income | −26.25B | 3.69B | 22.38B | 20.28B |
| Pre-tax income | −26.61B | 4.03B | 22.42B | 19.51B |
| Income tax | −4.27B | −1.49B | 3.79B | 2.73B |
| Net income | −22.33B | 5.52B | 18.63B | 16.78B |
| Earnings per share | −7.75 | 1.86 | 5.98 | 5.35 |
| Earnings per share, diluted | −7.75 | 1.84 | 5.94 | 5.31 |
| Metric | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 30.15B | 34.10B | 43.67B | — | — |
| Receivables | — | 5.66B | 5.51B | 6.43B | — |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | −4.65B | 1.54B | 17.95B | 19.96B |
| Depreciation and amortisation | 6.98B | 7.23B | 7.55B | 6.80B |
| Investing cash flow | −5.90B | −10.11B | −14.22B | −10.53B |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| Inventory | — | 22.15B | 20.86B | 21.41B | — | — |
| Current assets | — | 80.54B | 81.58B | 91.52B | — | — |
| Total assets | — | 195.15B | 207.61B | 202.13B | — | — |
| Current liabilities | — | 78.74B | 75.19B | 73.94B | — | — |
| Short-term debt | — | 14.12B | 12.20B | 9.46B | — | — |
| Long-term debt | — | 31.83B | 25.03B | 20.00B | — | — |
| Equity | — | 54.00B | 82.12B | 82.12B | 72.38B | 56.31B |
| Financing cash flow |
| 7.57B |
| −1.34B |
| −5.50B |
| −13.17B |